Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)

This study is currently recruiting participants.
Verified August 2013 by Vicus Therapeutics
Sponsor:
Information provided by (Responsible Party):
Vicus Therapeutics
ClinicalTrials.gov Identifier:
NCT01265576
First received: December 21, 2010
Last updated: August 27, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)